NKTR
NASDAQ · Pharmaceuticals
Nektar Therapeutics
$36.15
-2.33 (-6.06%)
Open$38.36
Previous Close$38.48
Day High$38.36
Day Low$35.76
52W High$109.00
52W Low$33.40
Volume—
Avg Volume554.4K
Market Cap1.25B
P/E Ratio—
EPS$-6.60
SectorPharmaceuticals
Analyst Ratings
Strong Buy
18 analysts
Price Target
+16.8% upside
Current
$36.15
$36.15
Target
$42.23
$42.23
$31.85
$42.23 avg
$63.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 113.29M | 134.34M | 246.52M |
| Net Income | -336,555,147 | -359,183,721 | 56.66M |
| Profit Margin | -297.1% | -282.2% | 23.0% |
| EBITDA | -285,272,827 | -321,367,467 | 106.98M |
| Free Cash Flow | — | — | 45.61M |
| Rev Growth | -15.7% | -15.7% | +15.2% |
| Debt/Equity | 0.70 | 0.70 | 0.88 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |